Soy Isoflavones for the Prevention of Menopausal Symptoms and Bone Loss— A Safe and Effective Alternative to Estrogen?

Abstract

Daily administration of soy isoflavones for 2 years did not prevent bone loss or menopausal symptoms.

References

Ahlborg

H. G.

Johnell

Nilsson

B. E.

Jeppson

Rannevik

, & Karlsson

M. K.

(2001). Bone loss in relation to menopause: A prospective study during 16 years. Bone, 28(3), 327–331.

Anderson

G. L.

Limacher

Assaf

A. R.

Bassford

Beresford

S. T.

Black

(2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. Journal of the American Medical Association, 291(14), 1701–1712.

Grady

(2006). Management of menopausal symptoms. New England Journal of Medicine, 355, 2338–2347.

Rossouw

J. E.

Anderson

G. L.

Prentice

R. L.

LaCroix

A. Z.

Kooperberg

Stefanick

M. L.

(2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association, 288(3), 321–333.

Shumaker

S. A.

Legault

Kuller

Rapp

S. R.

Thai

Lane

D. S.

(2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. Journal of the American Medical Association, 291(24), 2947–2958.

Shumaker

S. A.

Legault

Rapp

S. R.

Thai

Wallace

R. B.

Ockene

J. K.

(2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study. A randomized controlled trial. Journal of the American Medical Association, 289(20), 2651–2662.